# Arcutis Biotherapeutics, Inc.: Form 8-K, filed Oct 19, 2023

- Company: [Arcutis Biotherapeutics, Inc.](/companies/arqt.md) (CIK 1787306)
- Form: 8-K
- Filed: 2023-10-19
- Accepted by EDGAR: Oct 19, 2023, 16:02 ET
- Period: 2023-10-19
- Accession: 0001628280-23-034688
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1787306/000162828023034688/arqt-20231019.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1787306/000162828023034688/

## Items reported

- Item 2.02: Results of operations
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1787306/000162828023034688/arqt-20231019.htm

Filed Oct 19, 2023.
Source: SEC EDGAR, the filing index for accession 0001628280-23-034688. Last ingested by Listed: Oct 28, 2026, 09:04 ET. No prices; not investment advice.